Cargando…

Evaluation of Lymphocyte Subtypes in COVID-19 Patients

BACKGROUND: Although many aspects of the COVID-19 disease have not yet been clarified, dysregulation of the immune system may play a crucial role in the progression of the disease. In this study, the lymphocyte subsets were evaluated in patients with different severities of COVID-19. MATERIALS AND M...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rezaei, Mitra, Marjani, Majid, Tabarsi, Payam, Moniri, Afshin, Pourabdollah, Mihan, Abtahian, Zahra, Kazempour Dizaji, Mehdi, Dalil Roofchayee, Neda, Dezfuli, Neda K., Mansouri, Davood, Hossein-Khannazer, Nikoo, Varahram, Mohammad, Mortaz, Esmaeil, Velayati, Ali Akbar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	National Research Institute of Tuberculosis and Lung Disease 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10073943/ https://www.ncbi.nlm.nih.gov/pubmed/37025310

Ejemplares similares

Potential diagnostic value of pleural fluid cytokines levels for tuberculous pleural effusion
por: Dalil Roofchayee, Neda, et al.
Publicado: (2021)

Serum cytokine levels of COVID-19 patients after 7 days of treatment with Favipiravir or Kaletra
por: Mortaz, Esmaeil, et al.
Publicado: (2021)

Increased Serum Levels of Soluble TNF-α Receptor Is Associated With ICU Mortality in COVID-19 Patients
por: Mortaz, Esmaeil, et al.
Publicado: (2021)

T Helper Cell Subsets in the Pleural Fluid of Tuberculous Patients Differentiate Patients With Non-Tuberculous Pleural Effusions
por: Roofchayee, Neda Dalil, et al.
Publicado: (2021)

Not all that is miliary is tuberculosis: Metastatic medullary thyroid carcinoma mimicking miliary tuberculosis
por: Askari, Elham, et al.
Publicado: (2021)

Evaluation of Silymarin for management of anti-tuberculosis drug induced liver injury: a randomized clinical trial
por: Marjani, Majid, et al.
Publicado: (2019)

NRITLD Protocol for the Management of Outpatient Cases of COVID-19
por: Rezaei, Mitra, et al.
Publicado: (2021)

Evaluation Expression of miR-146a and miR-155 in Non-Small-Cell Lung Cancer Patients
por: Dezfuli, Neda K., et al.
Publicado: (2021)

Co‐infection of Klebsiella pneumonia, Cytomegalovirus, Aspergillus and Zygomycete in a patient with SARS‐CoV‐2
por: Pourabdollah Toutkaboni, Mihan, et al.
Publicado: (2022)

An adult autosomal recessive chronic granulomatous disease patient with pulmonary Aspergillus terreus infection
por: Mortaz, Esmaeil, et al.
Publicado: (2018)

Blood Purification Techniques, Inflammatory Mediators and Mortality in COVID-19 Patients
por: Hashemian, Seyed Mohammadreza, et al.
Publicado: (2020)

Evaluations of Factors Affecting of Short-and Long-Time of Occurrence of Disease Relapse in Patients with Tuberculosis Using Parametric Mixture Cure Model: A Cohort Study
por: Kazempour-Dizaji, Mehdi, et al.
Publicado: (2022)

Evaluation of Hepatoprotective Effect of Silymarin Among Under Treatment Tuberculosis Patients: A Randomized Clinical Trial
por: Marjani, Majid, et al.
Publicado: (2016)

Immunophenotype and function of circulating myeloid derived suppressor cells in COVID-19 patients
por: Kiaee, Fatemeh, et al.
Publicado: (2022)

Case Report: COVID-19-associated Rhinosinusitis Mucormycosis Caused by Rhizopus arrhizus: A Rare but Potentially Fatal Infection Occurring After Treatment with Corticosteroids
por: Tabarsi, Payam, et al.
Publicado: (2021)

The miR-146a SNP Rs2910164 and miR-155 SNP rs767649 Are Risk Factors for Non-Small Cell Lung Cancer in the Iranian Population
por: Dezfuli, Neda K., et al.
Publicado: (2020)

Serum Exosomal miRNAs Are Associated with Active Pulmonary Tuberculosis
por: Alipoor, Shamila D., et al.
Publicado: (2019)

Effect of pulmonary hypertension on outcome of pulmonary tuberculosis
por: Marjani, Majid, et al.
Publicado: (2014)

Etiology of Respiratory Complications among Iranian HIV Infected Patients
por: Marjani, Majid, et al.
Publicado: (2019)

Health Care Associated Middle East Respiratory Syndrome (MERS): A Case from Iran
por: Moniri, Afshin, et al.
Publicado: (2015)

The role of angiotensin I converting enzyme insertion/deletion polymorphism in the severity and outcomes of COVID-19 patients
por: Rezaei, Mitra, et al.
Publicado: (2022)

Toothpick Aspiration Induces Massive Hemoptysis: a Case Report
por: Rezaei, Mitra, et al.
Publicado: (2019)

Transmission electron microscopy study of suspected primary ciliary dyskinesia patients
por: Rezaei, Mitra, et al.
Publicado: (2022)

Decreased serum levels of angiotensin converting enzyme (ACE)2 and enhanced cytokine levels with severity of COVID-19: normalisation upon disease recovery
por: Mortaz, Esmaeil, et al.
Publicado: (2022)

Programmed Cell Death Protein 1 (PD-1) Molecule in Coronavirus Disease 2019 (COVID-19)?
por: Mortaz, Esmaeil, et al.
Publicado: (2021)

Interaction of Pattern Recognition Receptors with Mycobacterium Tuberculosis
por: Mortaz, Esmaeil, et al.
Publicado: (2014)

Update on Immunology of COVID-19 Disease and Potential Strategy for Controlling
por: Dezfuli, Neda K., et al.
Publicado: (2020)

Effective anti-mycobacterial treatment for BCG disease in patients with Mendelian Susceptibility to Mycobacterial Disease (MSMD): a case series
por: Mahdaviani, Seyed Alireza, et al.
Publicado: (2022)

NRITLD Protocol for the Management of Patients with COVID-19 Admitted to Hospitals
por: Marjani, Majid, et al.
Publicado: (2020)

Mixed etiology COVID-19 associated acute rhinosinusitis caused by two Aspergillus species
por: Tabarsi, Payam, et al.
Publicado: (2022)

Coinfection by Aspergillus and Mucoraceae Species in Two Cases of Acute Rhinosinusitis as a Complication of COVID-19
por: Tabarsi, Payam, et al.
Publicado: (2022)

Acute Epstein - Barr virus hepatitis without mononucleosis syndrome: a case report
por: Moniri, Afshin, et al.
Publicado: (2017)

A 60 Year-Old Man with AIDS and Pneumonia
por: Tabarsi, Payam, et al.
Publicado: (2013)

Cancers Related to Immunodeficiencies: Update and Perspectives
por: Mortaz, Esmaeil, et al.
Publicado: (2016)

Promising effects of tocilizumab in COVID-19: A non-controlled, prospective clinical trial
por: Dastan, Farzaneh, et al.
Publicado: (2020)

Trisomy 21 as a Risk Factor for Severe Illness in COVID-19: Report of two Cases
por: Babamahmoodi, Abdolreza, et al.
Publicado: (2020)

The Immune Response and Immunopathology of COVID-19
por: Mortaz, Esmaeil, et al.
Publicado: (2020)

Plasmapheresis reduces cytokine and immune cell levels in COVID-19 patients with acute respiratory distress syndrome (ARDS)
por: Hashemian, Seyed MohammadReza, et al.
Publicado: (2021)

Value of third sputum smear for detection of pulmonary tuberculosis in HIV infected patients
por: Marjani, Majid, et al.
Publicado: (2012)

National Research Institute of Tuberculosis and Lung Disease (NRITLD) Protocol for the Treatment of Patients with COVID-19
por: Mirenayat, Maryam Sadat, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_f715rkdjd276rt2un396kospj4